ArticleCancers2020

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study.

Manuela Tiako Meyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.